A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...

Cervical squamous cell carcinoma (CESC), the most prevalent subtype of cervical cancer, remains a major global health burden ...

Months before his death, Ralph Marcus explained how a COVID-era leg injury led to a rare bone cancer that didn’t have to be ...

The Liberty County football team is set to enter the playoffs on a six-game winning streak, but this season, the (7-2) team’s ...

As of July 31, 2025, the objective response rate (ORR) was 90% in NTRK fusion patients, as assessed by the Independent Review Committee (IRC). Among the patients who completed full efficacy ...

THURSDAY, Oct. 23, 2025 (HealthDay News) — Kids with a rare bone cancer might live longer if prescribed a drug that blocks ...

Libtayo is approved for adjuvant treatment in high-risk CSCC patients post-surgery and radiation, showing significant disease-free survival benefits in the C-POST trial. The C-POST trial excluded ...

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...

KIM-1 is overexpressed in kidney tumors and detectable in circulation years before RCC diagnosis, aiding early detection and risk stratification. High KIM-1 levels are associated with worse metastasis ...

Figure 1: (A, B) Axial and coronal sections of MRI showing a well-encapsulated, heterogeneous lesion measuring approximately 12 × 7.5 × 6 cm, originating from the belly of the sartorius muscle. (C) ...